|
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cmu | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cmu » |
Fluorine in PDB 4cmu: Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor (10R)-7-Amino-12-Fluoro-1,3,10, 16-Tetramethyl-16,17-Dihydro-1H-8,4-(Metheno)Pyrazolo(4,3- H)(2,5,11)Benzoxadiazacyclotetradecin-15(10H)-OneEnzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor (10R)-7-Amino-12-Fluoro-1,3,10, 16-Tetramethyl-16,17-Dihydro-1H-8,4-(Metheno)Pyrazolo(4,3- H)(2,5,11)Benzoxadiazacyclotetradecin-15(10H)-One
All present enzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor (10R)-7-Amino-12-Fluoro-1,3,10, 16-Tetramethyl-16,17-Dihydro-1H-8,4-(Metheno)Pyrazolo(4,3- H)(2,5,11)Benzoxadiazacyclotetradecin-15(10H)-One:
2.7.10.1; Protein crystallography data
The structure of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor (10R)-7-Amino-12-Fluoro-1,3,10, 16-Tetramethyl-16,17-Dihydro-1H-8,4-(Metheno)Pyrazolo(4,3- H)(2,5,11)Benzoxadiazacyclotetradecin-15(10H)-One, PDB code: 4cmu
was solved by
M.A.Mctigue,
Y.L.Deng,
W.Liu,
A.Brooun,
A.E.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor (10R)-7-Amino-12-Fluoro-1,3,10, 16-Tetramethyl-16,17-Dihydro-1H-8,4-(Metheno)Pyrazolo(4,3- H)(2,5,11)Benzoxadiazacyclotetradecin-15(10H)-One
(pdb code 4cmu). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor (10R)-7-Amino-12-Fluoro-1,3,10, 16-Tetramethyl-16,17-Dihydro-1H-8,4-(Metheno)Pyrazolo(4,3- H)(2,5,11)Benzoxadiazacyclotetradecin-15(10H)-One, PDB code: 4cmu: Fluorine binding site 1 out of 1 in 4cmuGo back to Fluorine Binding Sites List in 4cmu
Fluorine binding site 1 out
of 1 in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor (10R)-7-Amino-12-Fluoro-1,3,10, 16-Tetramethyl-16,17-Dihydro-1H-8,4-(Metheno)Pyrazolo(4,3- H)(2,5,11)Benzoxadiazacyclotetradecin-15(10H)-One
Mono view Stereo pair view
Reference:
T.W.Johnson,
P.F.Richardson,
S.Bailey,
A.Brooun,
B.J.Burke,
M.R.Collins,
J.J.Cui,
J.G.Deal,
Y.L.Deng,
D.M.Dinh,
L.D.Engstrom,
M.He,
J.E.Hoffman,
R.L.Hoffman,
Q.Huang,
J.Kath,
R.S.Kania,
H.Lam,
J.L.Lam,
P.T.Le,
L.Lingardo,
W.Liu,
M.A.Mctigue,
C.L.Palmer,
N.W.Sach,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.L.Timofeevski,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.P.Edwards.
Discovery of (10R)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15- Oxo-10,15,16,17-Tetrahydro-2H-8,4-(Metheno)Pyrazolo[4,3- H][2,5,11]Benzoxadiazacyclotetradecine-3-Carbonitrile (Pf- 06463922), A Macrocyclic Inhibitor of Alk/ROS1 with Pre- Clinical Brain Exposure and Broad Spectrum Potency Against Alk-Resistant Mutations. J.Med.Chem. V. 57 4720 2014.
Page generated: Thu Aug 1 00:45:35 2024
ISSN: ISSN 0022-2623 PubMed: 24819116 DOI: 10.1021/JM500261Q |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |